Vestmark Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.02M Buy
31,815
+7,488
+31% +$987K 0.04% 455
2026
Q1
$3.39M Buy
24,327
+16,167
+198% +$2.26M 0.04% 443
2025
Q4
$1M Buy
8,160
+6,317
+343% +$768K 0.01% 798
2025
Q3
$205K Sell
1,843
-84
-4% -$9.55K ﹤0.01% 887
2025
Q2
$214K Buy
+1,927
New +$205K ﹤0.01% 751
2023
Q3
Sell
-14,552
Closed -$1.12M 594
2023
Q2
$1.12M Sell
14,552
-2,475
-15% -$197K 0.04% 427
2023
Q1
$1.41M Sell
17,027
-2,968
-15% -$246K 0.06% 352
2022
Q4
$1.72M Buy
19,995
+897
+5% +$71K 0.08% 303
2022
Q3
$1.18M Sell
19,098
-1,378
-7% -$86.9K 0.07% 341
2022
Q2
$1.27M Buy
20,476
+465
+2% +$28.8K 0.07% 311
2022
Q1
$1.19M Buy
20,011
+932
+5% +$59.6K 0.07% 321
2021
Q4
$1.39M Sell
19,079
-7
-0% -$482 0.08% 303
2021
Q3
$1.33M Buy
19,086
+7,160
+60% +$503K 0.09% 286
2021
Q2
$821K Sell
11,926
-10
-0.1% -$668 0.06% 363
2021
Q1
$771K Buy
11,936
+556
+5% +$35.9K 0.07% 347
2020
Q4
$663K Sell
11,380
-545
-5% -$32.9K 0.07% 306
2020
Q3
$754K Buy
11,925
+245
+2% +$17K 0.1% 261
2020
Q2
$899K Sell
11,680
-4,662
-29% -$357K 0.14% 212
2020
Q1
$1.22M Sell
16,342
-4,840
-23% -$334K 0.24% 133
2019
Q4
$1.38M Sell
21,182
-239
-1% -$15.6K 0.28% 128
2019
Q3
$1.36M Buy
21,421
+4,682
+28% +$306K 0.22% 142
2019
Q2
$1.13M Buy
16,739
+8,298
+98% +$546K 0.19% 160
2019
Q1
$549K Buy
+8,441
New +$561K 0.1% 260

Other funds holding GILD

Vestmark Advisory Solutions's GILD Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $987K and bringing the position to 31,815 shares worth $4.02M. The position accounts for 0.04% of the portfolio, ranked #455.

Vestmark Advisory Solutions first reported a position in GILD in Q1 2019 and has held it in 23 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vestmark Advisory Solutions held 31,815 shares of Gilead Sciences worth $4.02M as of Q2 2026.
  • Vestmark Advisory Solutions bought 7,488 Gilead Sciences shares in Q2 2026, an estimated $987K.
  • Gilead Sciences made up 0.04% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #455 holding.
  • Vestmark Advisory Solutions first reported a position in Gilead Sciences in Q1 2019 and has held it in 23 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.